Genomic studies have revealed that mesothelioma is predominantly characterized by loss-of-function alterations in tumor suppressor genes, with mutations in CDKN2A, BAP1, and NF2 being the most frequently observed [5,6]. This evidence concerns the gene NF2 and mesothelioma.